| Palamuru University | INDIA
Dr. Pasula Janakiramulu is a dedicated researcher and academician with 6 years of combined research and teaching experience in the life sciences and pharmaceutical research sectors. He is currently serving as Assistant Professor (Part-Time) in the Department of Zoology at University P.G. Centre, Wanaparthy, Palamuru University, where he is actively engaged in teaching postgraduate students and conducting research in cancer biology and computational drug discovery. He emphasizes student-centered, concept-oriented, and experimental-based teaching approaches, integrating theoretical knowledge with practical demonstrations and real-world biological applications.
His academic journey reflects consistent scholarly progression through the pursuit of advanced qualifications. He completed his Ph.D. in Zoology from Kakatiya University in 2026, with his doctoral research focused on In Silico Prediction and In Vitro Validation of Anticancer Potential of Compounds from Selected Medicinal Plants under the supervision of Prof. M. Estari. Prior to his doctoral studies, he earned his M.Sc. in Zoology from Palamuru University (2018) and his B.Sc. in Botany, Zoology, and Chemistry from Kakatiya University (2016).
Research & Publications
Dr. Janakiramulu has established a focused research profile in cancer biology and computational drug discovery, with 5 years of active research experience. His research contributions center on identifying and computationally evaluating natural phytochemicals as potential anticancer agents, particularly investigating the inhibitory potential of medicinal plant-derived flavonoids against cancer-associated molecular targets such as EGFR and COX-2 using molecular docking and molecular dynamics simulations.
His research output includes 3 journal publications in peer-reviewed journals (SCI/Scopus indexed) and 3 proceedings publications presented at national seminars and conferences. Key publications include studies on molecular docking and dynamic simulation analysis of flavonoid derivatives as COX-2 inhibitors, and evaluations of the anti-cancer potential of natural flavonoids through computational approaches. His research citations total 51, with an h-index of 1 and i10-index of 1.
Patents & Scholarly Contributions
Dr. Janakiramulu holds 1 published patent titled Novel Apigenin–Quinazoline Hybrid Compound as A Potent Anti-Cancer Agent and Method of Preparation Thereof (Application No: 202641046846 A, Publication Date: 24/04/2026). This patent represents a significant contribution to the field of cancer therapeutics and drug development. His scholarly contributions extend across proceedings of national seminars, including presentations on phytochemical interactions with EGFR in cancer therapy, flavonoids as multifunctional agents in cancer therapy, and comprehensive reviews on Alzheimer's disease pathogenesis and emerging therapeutic strategies.
Professional Training & Technical Expertise
Dr. Janakiramulu possesses comprehensive technical expertise spanning both experimental and computational research methodologies. His skill set includes molecular docking and virtual screening, molecular dynamics simulations, machine learning applications in drug discovery, and ADMET prediction. He is proficient with specialized software including PyMOL, Discovery Studio, and UCSF Chimaera. In experimental techniques, he demonstrates expertise in high-performance liquid chromatography (HPLC) operation and method development, cell culture techniques, MTT assays, and spectral analysis including FT-IR, NMR, and LC-MS/MS. He has attended 10 workshops and training programs, including hands-on training in animal cell culture techniques, recombinant DNA technology, biomedical research, and online computational drug discovery courses.
Awards, Honours & Professional Memberships
Dr. Janakiramulu's achievements have been recognized through prestigious accolades. He received the Vice Chancellor's Award for Best Research Publication from Kakatiya University (January 26, 2026) in recognition of his outstanding research contributions. He has demonstrated exceptional aptitude through qualifying in the Telangana State Eligibility Test (SET-2023) and successfully qualifying the Graduate Aptitude Test in Engineering (GATE) on two occasions (2020 and 2022) in the Life Sciences discipline.
He maintains active professional engagement through multiple scholarly platforms. His professional memberships and identifiers include an ORCID ID (0009-0008-7025-5945), active profiles on Google Scholar and ResearchGate, establishing his presence in the global research community. He has actively participated in numerous national conferences, seminars, and workshops organized by leading academic institutions including Kakatiya University, Atmiya University, and Osmania University, demonstrating his commitment to continuous professional development and engagement with the broader scientific community.
Eligibility for Young Scientist Award
Dr. Janakiramulu demonstrates strong credentials for the Young Scientist Award through his combination of rigorous doctoral training, focused research contributions in cancer biology and computational drug discovery, a published patent representing innovative therapeutic development, peer-reviewed research publications in indexed journals, formal recognition through the Vice Chancellor's Award, demonstrated academic excellence through GATE qualifications and state eligibility certification, and comprehensive technical expertise in both experimental and computational research methodologies. His active participation in the academic and research community, coupled with his commitment to integrating research with teaching and student mentorship, reflects a promising trajectory in the life sciences.
Dr. Pasula Janakiramulu is eligible for consideration for the Young Scientist Award in Scientific Laurels, particularly in recognition of his contributions to cancer research, computational drug discovery, innovative patent development, and research-oriented teaching in the life sciences.